Hosted on MSN
MapLight’s ML-004 autism extension study: What ongoing safety data mean for investors
MapLight Therapeutics, Inc. (MPLT) announced an update on their ongoing clinical study. Study Overview MapLight Therapeutics is running an extension study called “An Open-label Extension Study to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results